128 related articles for article (PubMed ID: 28837200)
21. Discovery of novel and potent small-molecule inhibitors of NO and cytokine production as antisepsis agents: synthesis and biological activity of alkyl 6-(N-substituted sulfamoyl)cyclohex-1-ene-1-carboxylate.
Yamada M; Ichikawa T; Ii M; Sunamoto M; Itoh K; Tamura N; Kitazaki T
J Med Chem; 2005 Nov; 48(23):7457-67. PubMed ID: 16279805
[TBL] [Abstract][Full Text] [Related]
22. Structure property relationships of N-acylsulfonamides and related bioisosteres.
Francisco KR; Varricchio C; Paniak TJ; Kozlowski MC; Brancale A; Ballatore C
Eur J Med Chem; 2021 Jun; 218():113399. PubMed ID: 33823393
[TBL] [Abstract][Full Text] [Related]
23. Carbonic anhydrase inhibitory activity of sulfonamides and carboxylic acids incorporating cyclic imide scaffolds.
Abdel-Aziz AA; El-Azab AS; Ceruso M; Supuran CT
Bioorg Med Chem Lett; 2014 Nov; 24(22):5185-9. PubMed ID: 25442309
[TBL] [Abstract][Full Text] [Related]
24. Protective effect of novel substituted nicotine hydrazide analogues against hypoxic brain injury in neonatal rats via inhibition of caspase.
Deng CB; Li J; Li LY; Sun FJ
Bioorg Med Chem Lett; 2016 Jul; 26(13):3195-3201. PubMed ID: 27216999
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of biphenylsulfonamide carboxylate aggrecanase-1 inhibitors.
Xiang JS; Hu Y; Rush TS; Thomason JR; Ipek M; Sum PE; Abrous L; Sabatini JJ; Georgiadis K; Reifenberg E; Majumdar M; Morris EA; Tam S
Bioorg Med Chem Lett; 2006 Jan; 16(2):311-6. PubMed ID: 16275085
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and characterization of an N-acylsulfonamide inhibitor of human asparagine synthetase.
Koroniak L; Ciustea M; Gutierrez JA; Richards NG
Org Lett; 2003 Jun; 5(12):2033-6. PubMed ID: 12790521
[TBL] [Abstract][Full Text] [Related]
27. 4-Quinolone-3-carboxylic acids as cell-permeable inhibitors of protein tyrosine phosphatase 1B.
Zhi Y; Gao LX; Jin Y; Tang CL; Li JY; Li J; Long YQ
Bioorg Med Chem; 2014 Jul; 22(14):3670-83. PubMed ID: 24906513
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological caspase inhibitors: research towards therapeutic perspectives.
Kudelova J; Fleischmannova J; Adamova E; Matalova E
J Physiol Pharmacol; 2015 Aug; 66(4):473-82. PubMed ID: 26348072
[TBL] [Abstract][Full Text] [Related]
29. Novel inhibitors of the MDM2-p53 interaction featuring hydrogen bond acceptors as carboxylic acid isosteres.
Gonzalez AZ; Li Z; Beck HP; Canon J; Chen A; Chow D; Duquette J; Eksterowicz J; Fox BM; Fu J; Huang X; Houze J; Jin L; Li Y; Ling Y; Lo MC; Long AM; McGee LR; McIntosh J; Oliner JD; Osgood T; Rew Y; Saiki AY; Shaffer P; Wortman S; Yakowec P; Yan X; Ye Q; Yu D; Zhao X; Zhou J; Olson SH; Sun D; Medina JC
J Med Chem; 2014 Apr; 57(7):2963-88. PubMed ID: 24601644
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of 7-halogenated isatin sulfonamides: nonradioactive counterparts of caspase-3/-7 inhibitor-based potential radiopharmaceuticals for molecular imaging of apoptosis.
Limpachayaporn P; Wagner S; Kopka K; Schober O; Schäfers M; Haufe G
J Med Chem; 2014 Nov; 57(22):9383-95. PubMed ID: 25358116
[TBL] [Abstract][Full Text] [Related]
31. Small Molecule Active Site Directed Tools for Studying Human Caspases.
Poreba M; Szalek A; Kasperkiewicz P; Rut W; Salvesen GS; Drag M
Chem Rev; 2015 Nov; 115(22):12546-629. PubMed ID: 26551511
[TBL] [Abstract][Full Text] [Related]
32. Discovery of new indole-based acylsulfonamide Na
Wu YJ; Venables B; Guernon J; Chen J; Sit SY; Rajamani R; Knox RJ; Matchett M; Pieschl RL; Herrington J; Bristow LJ; Meanwell NA; Thompson LA; Dzierba C
Bioorg Med Chem Lett; 2019 Feb; 29(4):659-663. PubMed ID: 30638874
[TBL] [Abstract][Full Text] [Related]
33. Isatin sulfonamide analogs containing a Michael addition acceptor: a new class of caspase 3/7 inhibitors.
Chu W; Rothfuss J; d'Avignon A; Zeng C; Zhou D; Hotchkiss RS; Mach RH
J Med Chem; 2007 Jul; 50(15):3751-5. PubMed ID: 17585855
[TBL] [Abstract][Full Text] [Related]
34. MX1013, a dipeptide caspase inhibitor with potent in vivo antiapoptotic activity.
Yang W; Guastella J; Huang JC; Wang Y; Zhang L; Xue D; Tran M; Woodward R; Kasibhatla S; Tseng B; Drewe J; Cai SX
Br J Pharmacol; 2003 Sep; 140(2):402-12. PubMed ID: 12970077
[TBL] [Abstract][Full Text] [Related]
35. N-Acylsulfonamides strongly inhibit human carbonic anhydrase isoenzymes I and II.
Yıldırım A; Atmaca U; Keskin A; Topal M; Çelik M; Gülçin İ; Supuran CT
Bioorg Med Chem; 2015 May; 23(10):2598-605. PubMed ID: 25863492
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and evaluation of 1,2-benzisothiazol-3-one derivatives as potent caspase-3 inhibitors.
Liu D; Tian Z; Yan Z; Wu L; Ma Y; Wang Q; Liu W; Zhou H; Yang C
Bioorg Med Chem; 2013 Jun; 21(11):2960-7. PubMed ID: 23632366
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and activity of tryptophan sulfonamide derivatives as novel non-hydroxamate TNF-alpha converting enzyme (TACE) inhibitors.
Park K; Gopalsamy A; Aplasca A; Ellingboe JW; Xu W; Zhang Y; Levin JI
Bioorg Med Chem; 2009 Jun; 17(11):3857-65. PubMed ID: 19410464
[TBL] [Abstract][Full Text] [Related]
38. Metallo-β-lactamase inhibitors by bioisosteric replacement: Preparation, activity and binding.
Skagseth S; Akhter S; Paulsen MH; Muhammad Z; Lauksund S; Samuelsen Ø; Leiros HS; Bayer A
Eur J Med Chem; 2017 Jul; 135():159-173. PubMed ID: 28445786
[TBL] [Abstract][Full Text] [Related]
39. Peptide-based covalent inhibitors of MALT1 paracaspase.
Hatcher JM; Du G; Fontán L; Us I; Qiao Q; Chennamadhavuni S; Shao J; Wu H; Melnick A; Gray NS; Scott DA
Bioorg Med Chem Lett; 2019 Jun; 29(11):1336-1339. PubMed ID: 30954428
[TBL] [Abstract][Full Text] [Related]
40. Discovery of novel quinoline carboxylic acid series as DGAT1 inhibitors.
Zhou G; Ting PC; Wishart G; Zorn N; Aslanian RG; Lin M; Smith M; Walker SS; Cook J; Van Heek M; Lachowicz J
Bioorg Med Chem Lett; 2014 Apr; 24(7):1790-4. PubMed ID: 24618302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
